Wang Kevin H, Penmatsa Aravind, Gouaux Eric
Vollum Institute, Oregon Health &Science University, 3181 SW Sam Jackson Park Road, Portland, Oregon 97239, USA.
1] Vollum Institute, Oregon Health &Science University, 3181 SW Sam Jackson Park Road, Portland, Oregon 97239, USA [2] Howard Hughes Medical Institute, Oregon Health &Science University, 3181 SW Sam Jackson Park Road, Portland, Oregon 97239, USA.
Nature. 2015 May 21;521(7552):322-7. doi: 10.1038/nature14431. Epub 2015 May 11.
Na(+)/Cl(-)-coupled biogenic amine transporters are the primary targets of therapeutic and abused drugs, ranging from antidepressants to the psychostimulants cocaine and amphetamines, and to their cognate substrates. Here we determine X-ray crystal structures of the Drosophila melanogaster dopamine transporter (dDAT) bound to its substrate dopamine, a substrate analogue 3,4-dichlorophenethylamine, the psychostimulants d-amphetamine and methamphetamine, or to cocaine and cocaine analogues. All ligands bind to the central binding site, located approximately halfway across the membrane bilayer, in close proximity to bound sodium and chloride ions. The central binding site recognizes three chemically distinct classes of ligands via conformational changes that accommodate varying sizes and shapes, thus illustrating molecular principles that distinguish substrates from inhibitors in biogenic amine transporters.
钠/氯偶联生物胺转运体是治疗药物和滥用药物的主要作用靶点,这些药物包括从抗抑郁药到精神兴奋剂可卡因和苯丙胺,以及它们的同源底物。在这里,我们确定了与底物多巴胺、底物类似物3,4-二氯苯乙胺、精神兴奋剂d-苯丙胺和甲基苯丙胺、或可卡因及可卡因类似物结合的黑腹果蝇多巴胺转运体(dDAT)的X射线晶体结构。所有配体都结合到位于膜双层大约一半位置的中央结合位点,该位点紧邻结合的钠离子和氯离子。中央结合位点通过构象变化识别三类化学性质不同的配体,这些构象变化可适应不同的大小和形状,从而阐明了在生物胺转运体中区分底物与抑制剂的分子原理。